Cancer Antigen 15-3 CLIA Kit
- UID
- MFG/IVD/2021/000078_eede9819e00f919b1f3bf6e068fb3b52_2b1e5485e167e300922d7320d30316da
- Device class
- Class C
- Brand name
- AFP+CEA+PSA
- License holder
- Tosoh India Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- For the Quantitative Determination of Cancer Antigen 15-3 (AFP+CEA+PSA) Concentration in Human Serum by a Microplate Enzyme Immunoassay, Chemiluminescence
Cancer Antigen 15-3 CLIA Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000078_eede9819e00f919b1f3bf6e068fb3b52_2b1e5485e167e300922d7320d30316da. This device is marketed under the brand name AFP+CEA+PSA. The license holder is Tosoh India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.